View in EDS

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.

Saved in:
Bibliographic Details
Title: Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
Authors: Wilson GJ; Vanderbilt University Medical Center, Nashville, TN, United States., Rodriguez B; Case Western Reserve University, Cleveland, OH, United States., Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Allen M; DAIDS/NIAID/NIH, Rockville, MD, United States., Frank I; University of Pennsylvania, Philadelphia, PA, United States., Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Trahey M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Kalams S; Vanderbilt University Medical Center, Nashville, TN, United States., Hannaman D; Ichor Medical Systems, San Diego, CA, United States., Clarke DK; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Xu R; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Egan M; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Eldridge J; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Pensiero M; DAIDS/NIAID/NIH, Rockville, MD, United States., Latham T; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States., Ferrari G; Department of Surgery, Duke University, Durham, NC, United States., Montefiori DC; Department of Surgery, Duke University, Durham, NC, United States., Tomaras GD; Department of Surgery, Duke University, Durham, NC, United States., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Jacobson JM; Case Western Reserve University, Cleveland, OH, United States., Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States., Elizaga M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Corporate Authors: HIV Vaccine Trials Network 112 Protocol Team
Source: Vaccine [Vaccine] 2023 Apr 17; Vol. 41 (16), pp. 2696-2706. Date of Electronic Publication: 2023 Mar 17.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36935288
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wilson+GJ%22">Wilson GJ</searchLink>; Vanderbilt University Medical Center, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Rodriguez+B%22">Rodriguez B</searchLink>; Case Western Reserve University, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Li+SS%22">Li SS</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Allen+M%22">Allen M</searchLink>; DAIDS/NIAID/NIH, Rockville, MD, United States.<br /><searchLink fieldCode="AU" term="%22Frank+I%22">Frank I</searchLink>; University of Pennsylvania, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Rudnicki+E%22">Rudnicki E</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Trahey+M%22">Trahey M</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Kalams+S%22">Kalams S</searchLink>; Vanderbilt University Medical Center, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Hannaman+D%22">Hannaman D</searchLink>; Ichor Medical Systems, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Clarke+DK%22">Clarke DK</searchLink>; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.<br /><searchLink fieldCode="AU" term="%22Xu+R%22">Xu R</searchLink>; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.<br /><searchLink fieldCode="AU" term="%22Egan+M%22">Egan M</searchLink>; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.<br /><searchLink fieldCode="AU" term="%22Eldridge+J%22">Eldridge J</searchLink>; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.<br /><searchLink fieldCode="AU" term="%22Pensiero+M%22">Pensiero M</searchLink>; DAIDS/NIAID/NIH, Rockville, MD, United States.<br /><searchLink fieldCode="AU" term="%22Latham+T%22">Latham T</searchLink>; Auro Vaccines LLC (formerly Profectus Biosciences, Inc.), Pearl River, NY, United States.<br /><searchLink fieldCode="AU" term="%22Ferrari+G%22">Ferrari G</searchLink>; Department of Surgery, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Montefiori+DC%22">Montefiori DC</searchLink>; Department of Surgery, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Tomaras+GD%22">Tomaras GD</searchLink>; Department of Surgery, Duke University, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22De+Rosa+SC%22">De Rosa SC</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Jacobson+JM%22">Jacobson JM</searchLink>; Case Western Reserve University, Cleveland, OH, United States.<br /><searchLink fieldCode="AU" term="%22Miner+MD%22">Miner MD</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Elizaga+M%22">Elizaga M</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22HIV+Vaccine+Trials+Network+112+Protocol+Team%22">HIV Vaccine Trials Network 112 Protocol Team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228406899%22">Vaccine</searchLink> [Vaccine] 2023 Apr 17; Vol. 41 (16), pp. 2696-2706. <i>Date of Electronic Publication: </i>2023 Mar 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8406899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220264410X%22">0264410X </searchLink><i>NLM ISO Abbreviation: </i>Vaccine <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36935288
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.vaccine.2023.03.015
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2696
    Titles:
      – TitleFull: Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilson GJ
      – PersonEntity:
          Name:
            NameFull: Rodriguez B
      – PersonEntity:
          Name:
            NameFull: Li SS
      – PersonEntity:
          Name:
            NameFull: Allen M
      – PersonEntity:
          Name:
            NameFull: Frank I
      – PersonEntity:
          Name:
            NameFull: Rudnicki E
      – PersonEntity:
          Name:
            NameFull: Trahey M
      – PersonEntity:
          Name:
            NameFull: Kalams S
      – PersonEntity:
          Name:
            NameFull: Hannaman D
      – PersonEntity:
          Name:
            NameFull: Clarke DK
      – PersonEntity:
          Name:
            NameFull: Xu R
      – PersonEntity:
          Name:
            NameFull: Egan M
      – PersonEntity:
          Name:
            NameFull: Eldridge J
      – PersonEntity:
          Name:
            NameFull: Pensiero M
      – PersonEntity:
          Name:
            NameFull: Latham T
      – PersonEntity:
          Name:
            NameFull: Ferrari G
      – PersonEntity:
          Name:
            NameFull: Montefiori DC
      – PersonEntity:
          Name:
            NameFull: Tomaras GD
      – PersonEntity:
          Name:
            NameFull: De Rosa SC
      – PersonEntity:
          Name:
            NameFull: Jacobson JM
      – PersonEntity:
          Name:
            NameFull: Miner MD
      – PersonEntity:
          Name:
            NameFull: Elizaga M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 04
              Text: 2023 Apr 17
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1873-2518
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Vaccine
              Type: main
ResultId 1